What is iCleanse?
iCleanse offers innovative Swift UV units designed to improve phone hygiene and create new advertising revenue streams for businesses. These units are capable of disinfecting high-touch surfaces such as mobile phones, tablets, and body cameras, finding critical applications in over 100 U.S. hospitals. Beyond their rapid 15-second disinfection cycle, the Swift UV stations feature high-resolution 10-inch LCD displays, enabling businesses to showcase digital content for educational purposes, branding, or advertising, thereby engaging audiences effectively.
How much funding has iCleanse raised?
iCleanse has raised a total of $2.5M across 2 funding rounds:
Debt
$1.5M
Debt
$1M
Debt (2022): $1.5M with participation from Enhanced Capital
Debt (2023): $1M led by Enhanced Capital
Key Investors in iCleanse
Enhanced Capital
Enhanced Capital is a diversified national asset management firm that provides investment capital to small businesses underserved by traditional financing sources. The company focuses on strategies such as project finance, sustainable infrastructure, and real estate, aiming to unlock private sector resources aligned with public policy goals.
What's next for iCleanse?
The recent major strategic investment signals iCleanse's transition into a scaling phase, likely aimed at expanding its market reach and enhancing its technological capabilities. With a focus on hygiene solutions integrated with digital advertising, the company is well-positioned to capitalize on increasing public health awareness and the growing demand for innovative business solutions. Future endeavors may include further integration of disinfection technology with interactive advertising platforms and broader deployment across various commercial and public sectors.
See full iCleanse company page
